Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05666856 · ClinicalTrials.gov registry record · NA

Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones

A NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.

Active
Registry status
NA
Development phase
212
Enrollment target
1
Study location

NCT05666856 is a NA study of Substance-Related Disorders and Family Health that is active but no longer recruiting, run by We The Village. The registered enrollment target is 212 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05666856, a NA study of Substance-Related Disorders and Family Health, is active but no longer recruiting, sponsored by We The Village.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than 42,000 have died of overdose involving opioids. This death rate is more than any year on record and has quadrupled since 1999 (1,2). Leveraging the potential of available data bases and health IT technologies may help to combat opioid crisis by targeting various aspects of the problem ranging from the prevention of opioid misuse to OUD treatment. NIH through NIDA solicits the research and development of data-driven solutions and services that focus on issues related to opioid use prevention, opioid use, opioid overdose prevention or OUD treatment. In this project, We The Village, Inc. will address a need to prepare Concerned Significant Others (CSOs) to best use their influence over the trajectory of a loved one's OUD. CSOs are motivated to help, make majority of treatment decisions and payments and have influence over treatment entry and thus, impact the trajectory of an OUD. The goal of the project is to establish the technical efficacy and commercial viability of CRAFT-A at scale by conducting the fully powered randomized controlled trial (RCT) comparing two online interventions: CRAFT-A (hereinafter referred to as CRAFT or digital CRAFT) and PEER support (the original comparison group). Based on Phase I findings, the team anticipates the CRAFT condition will achieve better outcomes than the PEER condition in a) treatment entry and retention, b) Concerned Significant Others' (CSO) health and wellbeing, c) CSO-IP relationship, and d) CRAFT knowledge.

Interventions

  • BEHAVIORAL Community Reinforcement And Family Training
  • BEHAVIORAL We The Village Peer Community Forum

Study Locations (1)

New York

  • We The Village, Inc. - New York

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2022-11-29
Est. Completion 2024-09-22
Phase NA

Sponsor

We The Village

4 total trials

What the Registry Record Tells You About NCT05666856

The ClinicalTrials.gov registry entry for NCT05666856 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (86% lower). The listed sponsor is We The Village, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Community Reinforcement And Family Training is the first listed.

NCT05666856 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05666856 about?

NCT05666856 is a clinical study titled "Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones". The United States is in the midst of an opioid crisis. Over-prescription of opioid analgesic pain relievers contributed to a rapid escalation of use and misuse of these substances across the country. In 2016, more than 2.6 million Americans were diagnosed with opioid use disorder (OUD) and more than...

What is the current status of trial NCT05666856?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2022-11-29. Estimated completion is 2024-09-22.

What conditions does trial NCT05666856 study?

This clinical trial studies the following conditions: Substance-Related Disorders, Family Health, Community Reinforcement And Family Training.

What interventions are being tested in trial NCT05666856?

The interventions under investigation include: Community Reinforcement And Family Training (BEHAVIORAL), We The Village Peer Community Forum (BEHAVIORAL).

Who is sponsoring clinical trial NCT05666856?

This trial is sponsored by We The Village, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05666856 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.